Matrix metalloproteinase-9: Many shades of function in cardiovascular disease.
about
The circular relationship between matrix metalloproteinase-9 and inflammation following myocardial infarctionChelation therapy to treat atherosclerosis, particularly in diabetes: is it time to reconsider?Myofibroblasts and the extracellular matrix network in post-myocardial infarction cardiac remodelingCardiac-restricted overexpression or deletion of tissue inhibitor of matrix metalloproteinase-4: differential effects on left ventricular structure and function following pressure overload-induced hypertrophy.Cardiac extracellular proteome profiling and membrane topology analysis using glycoproteomics.Uric acid promotes left ventricular diastolic dysfunction in mice fed a Western diet.Salivary Matrix Metalloproteinase-8 and -9 and Myeloperoxidase in Relation to Coronary Heart and Periodontal Diseases: A Subgroup Report from the PAROKRANK Study (Periodontitis and Its Relation to Coronary Artery Disease)Matrix Metalloproteinase 9 Exerts Antiviral Activity against Respiratory Syncytial VirusEffects of adenotonsillectomy on plasma inflammatory biomarkers in obese children with obstructive sleep apnea: A community-based study.Wnt10b Gain-of-Function Improves Cardiac Repair by Arteriole Formation and Attenuation of Fibrosis.Cyp26 Enzymes Facilitate Second Heart Field Progenitor Addition and Maintenance of Ventricular Integrity.Metalloproteinase-9 contributes to endothelial dysfunction in atherosclerosis via protease activated receptor-1.Association of endothelin-1 and matrix metallopeptidase-9 with metabolic syndrome in middle-aged and older adults.Morin Attenuates Ovalbumin-Induced Airway Inflammation by Modulating Oxidative Stress-Responsive MAPK Signaling.Thrombospondins in the transition from myocardial infarction to heart failure.Systemic inflammation on postnatal days 21 and 28 and indicators of brain dysfunction 2years later among children born before the 28th week of gestation.Tissue Inhibitor of Metalloproteinase-1: Actions beyond Matrix Metalloproteinase Inhibition.Investigation of MMP-2 and MMP-9 activities in canine sera with dilated cardiomyopathyThe association between blood glucose levels and matrix-metalloproteinase-9 in early severe sepsis and septic shockMatrix metalloproteinase-9-dependent mechanisms of reduced contractility and increased stiffness in the aging heartEvaluation of physiological risk factors, oxidant-antioxidant imbalance, proteolytic and genetic variations of matrix metalloproteinase-9 in patients with pressure ulcer.MMP-9 signaling in the left ventricle following myocardial infarction.Effects of resveratrol on ARPE-19 cell proliferation and migration via regulating the expression of proliferating cell nuclear antigen, P21, P27 and p38MAPK/MMP-9Pleiotropic Effects of Myocardial MMP-9 Inhibition to Prevent Ventricular Arrhythmia.Myocardial Infarction Superimposed on Aging: MMP-9 Deletion Promotes M2 Macrophage Polarization.System-based proteomic and metabonomic analysis of the Df(16)A+/- mouse identifies potential miR-185 targets and molecular pathway alterationsIschemia/Reperfusion Injury following Acute Myocardial Infarction: A Critical Issue for Clinicians and Forensic Pathologists.Catalytically defective receptor protein tyrosine kinase PTK7 enhances invasive phenotype by inducing MMP-9 through activation of AP-1 and NF-κB in esophageal squamous cell carcinoma cells.Correlation between the severity of coronary artery lesions and levels of estrogen, hs-CRP and MMP-9.Cannabinoid Receptor 2 Modulates Neutrophil Recruitment in a Murine Model of Endotoxemia.Autodigestion: Proteolytic Degradation and Multiple Organ Failure in ShockArterial wall remodeling under sustained axial twisting in rats.Phosphorylation of STAT3 at Tyr705 regulates MMP-9 production in epithelial ovarian cancer.Matrix Metalloproteinases in Myocardial Infarction and Heart Failure.Practical alternatives to chronic caloric restriction for optimizing vascular function with ageing.Biomarkers to Predict Reverse Remodeling and Myocardial Recovery in Heart Failure.Hypertension-induced remodelling: on the interactions of cardiac risk factors.Microcurrent stimulation promotes reverse remodelling in cardiomyocytesThe Matrikine Acetylated Proline-Glycine-Proline Couples Vascular Inflammation and Acute Cardiac Rejection.Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1 Positively Modulates Matrix Metalloproteinase-9 Production in Alveolar Macrophages upon Toll-Like Receptor 7 Signaling and Influenza Virus Infection.
P2860
Q26798328-042C052B-2608-422A-ACD9-EB6239FD1444Q28393954-EE615685-BF2A-4DFF-8EB6-E9BA338C0852Q33663388-7FFC4D62-9139-4884-BA3F-F7E8A8FBC9C9Q34296764-9C4EE1BF-5FCD-49D3-8158-EDE3CC9545E8Q34420019-8732733F-D163-42DC-9193-FCADBD5298F0Q35208175-167E4043-5112-4669-857F-E88DDC594384Q35680166-AEB1BE8E-E404-4912-9174-42B34F9E1E9CQ35748831-F81F511C-4C2C-4423-919C-246B31084015Q35832496-CEA8F9E6-ABCE-49A5-BC20-664349407A6AQ36144944-85FE1C55-3AC3-4D9D-BB99-A9F20901D10EQ36205433-F3F15C95-F54A-4983-9BF6-A546BF916A5EQ36271765-2F55DABC-9EB2-4992-8C86-878E58C5D650Q36364214-AA4D59AA-AB27-4F23-90EC-2D1F52A16090Q36405265-0B49E015-FF52-4338-9F11-AF87ADA0EA8FQ36479630-8E9B3951-506A-42E7-B9CD-CF97DB7240EFQ36522018-AEAD8838-152A-4809-B7D9-029D1495F5C2Q36526033-C7ECA61D-06A5-4B63-B16D-230BC7F5AC49Q36787202-EBD832EE-6A32-421F-A3B5-2891D098E764Q36825585-4068090C-B4EF-450F-8C11-00D5A54D5614Q37041149-27C49F84-99C7-403E-834F-CB9605ADD33AQ37088998-0AE5CD14-1927-46F6-87E4-A62A4531506DQ37139613-4AC1B728-8452-4AF2-9640-73CCE8A11F86Q37500491-128662EE-0C40-4DF2-AD04-9340FFB08A7AQ37501402-3BF5E319-2D58-4CA4-A520-A00990CEDB78Q37523384-96272019-33A3-4DC7-99F8-11892C304B74Q37660911-D65DE3C3-2376-4983-9655-D7B586FBEE0BQ37668843-3597699F-D3D2-40E0-A0F9-9B99C3F42C3CQ37687371-B13CCFF3-E895-4BDF-B164-5376CDC182C8Q37709981-CEC129B9-F45D-4E98-9343-1B478E554684Q38602925-632E5A2D-387B-416C-BAE7-3973F6F6E8FFQ38683032-4F17F1BD-2AFD-4109-AF7F-A7E9E05FD7FAQ38685711-6B462285-5351-473C-9FE2-68EA91847ED4Q38693670-2BB22F84-3B4F-4B43-AF49-E9E084873A07Q38729906-AA8D146B-42E8-4E91-A1EE-F746D12F0ABCQ38957934-C67A13FE-596E-450D-8DE7-47499B7E28C7Q38977493-081B8324-33F8-49B2-9013-C6C2C78B40E8Q39144071-3CB2BAFE-D690-470D-AD36-18DE0F82F6A0Q39256520-AEF3BB99-92DE-4CE7-8C52-8656A70B8BA1Q41308721-1C2C9E52-B70A-4C3C-B025-1C90CF116F0CQ41919605-AB18FC54-73FF-4088-BCBB-1B2705B18A5C
P2860
Matrix metalloproteinase-9: Many shades of function in cardiovascular disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Matrix metalloproteinase-9: Many shades of function in cardiovascular disease.
@en
Matrix metalloproteinase-9: Many shades of function in cardiovascular disease.
@nl
type
label
Matrix metalloproteinase-9: Many shades of function in cardiovascular disease.
@en
Matrix metalloproteinase-9: Many shades of function in cardiovascular disease.
@nl
prefLabel
Matrix metalloproteinase-9: Many shades of function in cardiovascular disease.
@en
Matrix metalloproteinase-9: Many shades of function in cardiovascular disease.
@nl
P2093
P2860
P1433
P1476
Matrix metalloproteinase-9: Many shades of function in cardiovascular disease
@en
P2093
Michael E Hall
Rugmani Padmanabhan Iyer
Yonggang Ma
P2860
P304
P356
10.1152/PHYSIOL.00029.2013
P577
2013-11-01T00:00:00Z